ImmunityBio, Inc. — Investor Relations & Filings
ImmunityBio, Inc. is a commercial-stage biotechnology company developing next-generation immunotherapies and vaccines designed to strengthen a patient's own immune system. The company's approach focuses on orchestrating both the innate (natural killer cells) and adaptive (T cells) immune systems to combat cancer and infectious diseases. Its key platforms include the IL-15 superagonist Anktiva® (N-803), engineered natural killer (NK) cell therapies, and adenovirus-vectored vaccines. These therapies are being investigated and applied across a range of difficult-to-treat cancers, such as bladder, lung, and pancreatic cancers, as well as infectious diseases like HIV. The company's goal is to create durable, complete responses by treating the host's immune system rather than just the disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| 10-Q - ImmunityBio, Inc. (0001326110) (Filer) | 2026-05-07 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-05-07 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-04-09 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-04-06 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-03-31 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BY-HEALTH CO.,LTD
Researches, develops, and distributes dietary supplements, …
|
300146 | CN | Manufacturing |
|
C4 Therapeutics, Inc.
Clinical-stage biopharma developing targeted protein degrad…
|
CCCC | US | Manufacturing |
|
Cadrenal Therapeutics, Inc.
A late-stage biopharmaceutical company developing novel ant…
|
CVKD | US | Manufacturing |
|
CalciMedica, Inc.
Develops CRAC channel inhibitors for acute inflammatory and…
|
CALC | US | Manufacturing |
|
Calidi Biotherapeutics, Inc.
Develops stem cell platforms to deliver oncolytic viruses f…
|
CLDI | US | Manufacturing |
|
Calliditas Therapeutics
Biopharma company developing and commercializing treatments…
|
CALTX | SE | Manufacturing |
|
Callitas Health Inc.
Clinical-stage biomedical company developing pharma and OTC…
|
MPHMF | CA | Manufacturing |
|
CALTH. Inc
Develops in vitro diagnostic tools for point-of-care and se…
|
402420 | KR | Manufacturing |
|
Cambrex
A CDMO providing drug substance, drug product, and analytic…
|
CBM | US | Manufacturing |
|
CAMBRIDGE NUTRITIONAL SCIENCES PLC
Develops and manufactures diagnostic tests for food sensiti…
|
CNSL | GB | Manufacturing |
ImmunityBio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31529/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31529 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31529 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31529 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31529}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ImmunityBio, Inc. (id: 31529)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.